
BioLife Solutions, Inc.
BLFSNASDAQHealthcare● Active
$26.64
$-0.01(-0.04%)
Market Cap$1.3B
P/E Ratio—
52W High$29.62
52W Low$17.86
BioLife Solutions, Inc.(BLFS)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · BLFS · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $96.21M | $82.25M | $75.86M | $76.24M | $119.16M |
| Cost of Revenue | $34.10M | $28.58M | $96.52M | $29.33M | $90.31M |
| Gross Profit | $62.12M | $53.67M | $46.75M | $46.91M | $28.85M |
| Gross Margin %(computed) | 64.56% | 65.25% | 61.63% | 61.53% | 24.21% |
| Operating Expenses | |||||
| R&D Expenses | $7.57M | $7.91M | $18.80M | $14.80M | $11.82M |
| G&A Expenses | $45.52M | $40.54M | $43.26M | $33.26M | $34.10M |
| Total Operating Expenses | $74.25M | $60.80M | $117.58M | $52.83M | $73.34M |
| Operating Income | ($12.13M) | ($7.13M) | ($23.44M) | ($5.92M) | ($35.16M) |
| Operating Margin %(computed) | -12.61% | -8.67% | -30.90% | -7.77% | -29.51% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $2.71M | $0.72M | $1.81M | $0.69M | $0.48M |
| Income Before Tax | ($12.08M) | ($11.43M) | ($18.47M) | ($4.85M) | ($29.03M) |
| Income Tax Expense | $0.05M | ($0.04M) | $0.02M | ($5.24M) | ($20.12M) |
| Net Income | ($12.13M) | ($20.18M) | ($66.43M) | ($139.81M) | ($8.91M) |
| Net Margin %(computed) | -12.61% | -24.54% | -87.57% | -183.38% | -7.48% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.25 | $-0.44 | $-1.52 | $-3.29 | $-0.23 |
| Wtd Avg Shares | 47.75M | 46.07M | 43.72M | 42.48M | 38.50M |
| EBITDA | ($9.38M) | $1.53M | ($45.24M) | ($124.18M) | ($16.65M) |
| EBITDA Margin %(computed) | -9.74% | 1.86% | -59.64% | -162.89% | -13.98% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M
深入了解BioLife Solutions, Inc.
关于BioLife Solutions, Inc.(BLFS)损益表
BioLife Solutions, Inc.(BLFS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,BLFS实现营收$0.10B,毛利润$0.06B(毛利率64.56%),净利润($0.01B)(净利率-12.61%)。
常见问题
BLFS · 4 问BioLife Solutions, Inc.(BLFS)2025财年营收为$0.10B,同比up17.0%。
BLFS revenueBLFS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08